Beneficial modulation of the gut microbiota

FEBS Letters

Volumn 588, Issue 22, 2014, Pages 4120-4130

  Walsh, Calum J ^a,b   Guinane, Caitriona M ^a   O'Toole, Paul W ^b,c   Cotter, Paul D ^a,c  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antimicrobial; Diet; Faecal microbiota transplantation; Gut health; Microbial modulation; Microbiota

Indexed keywords

AMOXICILLIN; AMPICILLIN; BACTERIOCIN; BISMUTH; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; METRONIDAZOLE; PREBIOTIC AGENT; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THURICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ALLERGY; ARTICLE; CARBOHYDRATE DIET; CLOSTRIDIUM DIFFICILE INFECTION; COLORECTAL CANCER; COMMUNITY STRUCTURE; DIARRHEA; DIETARY INTAKE; FECES MICROFLORA; HELICOBACTER INFECTION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; LIPID DIET; MICROBIAL COMMUNITY; MICROBIAL DEGRADATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN DEGRADATION; PROTEIN DIET; ANIMAL; DIET THERAPY; DRUG EFFECTS; FECES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA;

ANIMALS; ANTI-INFECTIVE AGENTS; FECES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; PROBIOTICS;

EID: 84908322926     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.03.035     Document Type: Review

References (143)

1. R.E. Ley Evolution of mammals and their gut microbes Science 320 2008 1647 1651
2. J. Qin A human gut microbial gene catalogue established by metagenomic sequencing Nature 464 2010 59 65
3. J.C. Clemente, L.K. Ursell, L.W. Parfrey, and R. Knight The impact of the gut microbiota on human health: an integrative view Cell 148 2012 1258 1270
4. P.J. Turnbaugh, and J.I. Gordon The core gut microbiome, energy balance and obesity J. Physiol. 587 2009 4153 4158
5. I. Sekirov, S.L. Russell, L.C.M. Antunes, and B.B. Finlay Gut microbiota in health and disease Physiol. Rev. 90 2010 859 904
6. J.F. Cryan, and S.M. O'Mahony The microbiome-gut-brain axis: from bowel to behavior Neurogastroenterol. Motil. 23 2011 187 192
7. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome Nature 486 2012 207 214
8. A.M. O'Hara, and F. Shanahan The gut flora as a forgotten organ EMBO Rep. 7 2006 688 693
9. I. Adlerberth, and A.E. Wold Establishment of the gut microbiota in Western infants Acta Paediatr. 98 2009 229 238
10. M.G. Dominguez-Bello, E.K. Costello, and R. Knight Reply to Putignani et al.: vagina as a major source of natural inoculum for the newborn Proc. Natl. Acad. Sci. 107 2010 E160
11. C. Palmer, E.M. Bik, D.B. DiGiulio, D.A. Relman, and P.O. Brown Development of the human infant intestinal microbiota PLoS Biol. 5 2007 e177
12. M.J. Claesson Composition, variability, and temporal stability of the intestinal microbiota of the elderly Proc. Natl. Acad. Sci. U.S.A. 108 Suppl. 1 2011 4586 4591
13. C. Franceschi Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr. Rev. 65 2007 S173 S176
14. F. Karlsson, V. Tremaroli, J. Nielsen, and F. Backhed Assessing the human gut microbiota in metabolic diseases Diabetes 62 2013 3341 3349
15. C.A. Anderson Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 Nat. Genet. 43 2011 246 252
16. A. Franke Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci Nat. Genet. 42 2010 1118 1125
17. L. Jostins Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
18. M.E. Spehlmann, A.Z. Begun, J. Burghardt, P. Lepage, A. Raedler, and S. Schreiber Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study Inflamm. Bowel Dis. 14 2008 968 976
19. R.K. Sellon, S. Tonkonogy, M. Schultz, L.A. Dieleman, W. Grenther, E. Balish, D.M. Rennick, and R.B. Sartor Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice Infect. Immun. 66 1998 5224 5231
20. W.S. Garrett Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis Cell Host Microbe 8 2010 292 300
21. D.N. Frank, A.L.S. Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, and N.R. Pace Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc. Natl. Acad. Sci. 104 2007 13780 13785
22. H. Sokol, and P. Seksik The intestinal microbiota in inflammatory bowel diseases: time to connect with the host Curr. Opin. Gastroenterol. 26 2010 327 331
23. C.O. Elson, and Y. Cong Host-microbiota interactions in inflammatory bowel disease Gut Microbes 3 2012 332 344
24. K. Machiels A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis Gut 2013 10.1136/gutjnl-2013-304833
25. R. Hansen Microbiota of de-novo pediatric IBD: increased Faecalibacterium Prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative Colitis Am. J. Gastroenterol. 107 2012 1913 1922
26. P. Lepage Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis Gastroenterology 141 2011 227 236
27. L. Ohman, and M. Simren Intestinal microbiota and its role in irritable bowel syndrome (IBS) Curr. Gastroenterol. Rep. 15 2013 323
28. M. Rajilic-Stojanovic, E. Biagi, H.G. Heilig, K. Kajander, R.A. Kekkonen, S. Tims, and W.M. de Vos Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome Gastroenterology 141 2011 1792 1801
29. J. Jalanka-Tuovinen Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome Gut 2013
30. H.C. Lin Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome JAMA 292 2004 852 858
31. S.M. Riordan, and R. Kim Bacterial overgrowth as a cause of irritable bowel syndrome Curr. Opin. Gastroenterol. 22 2006 669 673
32. Y. Bouhnik, S. Alain, A. Attar, B. Flourie, L. Raskine, M.J. Sanson-Le Pors, and J.C. Rambaud Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome Am. J. Gastroenterol. 94 1999 1327 1331
33. M. Pimentel Rifaximin therapy for patients with irritable bowel syndrome without constipation N. Engl. J. Med. 364 2011 22 32
34. E.K. Brint, J. MacSharry, A. Fanning, F. Shanahan, and E.M. Quigley Differential expression of toll-like receptors in patients with irritable bowel syndrome Am. J. Gastroenterol. 106 2011 329 336
35. F. Backhed, H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, A. Nagy, C.F. Semenkovich, and J.I. Gordon The gut microbiota as an environmental factor that regulates fat storage Proc. Natl. Acad. Sci. U.S.A. 101 2004 15718 15723
36. P.D. Cani Gut microbiota and obesity: lessons from the microbiome Brief. Funct. Genomics 12 2013 381 387
37. S.F. Clarke, E.F. Murphy, K. Nilaweera, P.R. Ross, F. Shanahan, P.W. O'Toole, and P.D. Cotter The gut microbiota and its relationship to diet and obesity: new insights Gut Microbes 3 2012 186 202
38. R.E. Ley, F. Bäckhed, P. Turnbaugh, C.A. Lozupone, R.D. Knight, and J.I. Gordon Obesity alters gut microbial ecology Proc. Natl. Acad. Sci. U.S.A. 102 2005 11070 11075
39. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031
40. P.J. Turnbaugh, F. Bäckhed, L. Fulton, and J.I. Gordon Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome Cell Host Microbe 3 2008 213 223
41. P.J. Turnbaugh, V.K. Ridaura, J.J. Faith, F.E. Rey, R. Knight, and J.I. Gordon The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice Sci. Transl. Med. 1 2009 6ra14
42. V.K. Ridaura Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 341 2013 1241214
43. A. Everard Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity Proc. Natl. Acad. Sci. U.S.A. 110 2013 9066 9071
44. Wellcome Trust Case Control Consortium (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.
45. L.J. Scott A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants Science 316 2007 1341 1345
46. N. Larsen Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults PLoS ONE 5 2010 e9085
47. G. Musso, R. Gambino, and M. Cassader Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes Annu. Rev. Med. 62 2011 361 380
48. J. Qin A metagenome-wide association study of gut microbiota in type 2 diabetes Nature 490 2012 55 60
49. V. Lyssenko Clinical risk factors, DNA variants, and the development of type 2 diabetes N. Engl. J. Med. 359 2008 2220 2232
50. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
51. J.C. Arthur Intestinal inflammation targets cancer-inducing activity of the microbiota Science 338 2012 120 123
52. C.S. Plottel, and M.J. Blaser Microbiome and malignancy Cell Host Microbe 10 2011 324 335
53. T. Wang Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers ISME J. 6 2012 320 329
54. A.D. Kostic Genomic analysis identifies association of Fusobacterium with colorectal carcinoma Genome Res. 22 2012 292 298
55. M. Castellarin Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma Genome Res. 22 2012 299 306
56. A.N. McCoy, F. Araujo-Perez, A. Azcarate-Peril, J.J. Yeh, R.S. Sandler, and T.O. Keku Fusobacterium is associated with colorectal adenomas PLoS ONE 8 2013 e53653
57. T. Tahara Fusobacterium in colonic flora and molecular features of colorectal carcinoma Cancer Res. 2014
58. A.D. Kostic Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment Cell Host Microbe 14 2013 207 215
59. F. Bäckhed, R.E. Ley, J.L. Sonnenburg, D.A. Peterson, and J.I. Gordon Host-bacterial mutualism in the human intestine Science 307 2005 1915 1920
60. M.J. Claesson Gut microbiota composition correlates with diet and health in the elderly Nature 488 2012 178 184
61. L.A. David Diet rapidly and reproducibly alters the human gut microbiome Nature 2013
62. G.D. Wu Linking long-term dietary patterns with gut microbial enterotypes Science 334 2011 105 108
63. S.H. Duncan, A. Belenguer, G. Holtrop, A.M. Johnstone, H.J. Flint, and G.E. Lobley Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces Appl. Environ. Microbiol. 73 2007 1073 1078
64. G.T. Macfarlane, and S. Macfarlane Bacteria, colonic fermentation, and gastrointestinal health J. AOAC Int. 95 2012 50 60
65. A.W. Walker, S.H. Duncan, E.C.M. Leitch, M.W. Child, and H.J. Flint PH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon Appl. Environ. Microbiol. 71 2005 3692 3700
66. G. Macfarlane, J. Cummings, and C. Allison Protein degradation by human intestinal bacteria J. Gen. Microbiol. 132 1986 1647 1656
67. J. Cummings, and G. Macfarlane The control and consequences of bacterial fermentation in the human colon J. Appl. Microbiol. 70 1991 443 459
68. S.K. Clinton, D.G. Bostwick, L.M. Olson, H.J. Mangian, and W.J. Visek Effects of ammonium acetate and sodium cholate on N-methyl-N′-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats Cancer Res. 48 1988 3035 3039
69. H.M. Hamer, V. De Preter, K. Windey, and K. Verbeke Functional analysis of colonic bacterial metabolism: relevant to health? Am. J. Physiol. Gastrointest. Liver Physiol. 302 2012 G1 G9
70. E.F. Lhoste, B. Mouzon, C. Andrieux, A.M. Gueugneau, M. Fiszlewicz, T. Corring, and O. Szylit Physiological effects of a pea protein isolate in gnotobiotic rats: comparison with a soybean isolate and meat Ann. Nutr. Metab. 42 1998 44 54
71. E.A. Magee, C.J. Richardson, R. Hughes, and J.H. Cummings Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans Am. J. Clin. Nutr. 72 2000 1488 1494
72. P.C. Elwood, D.I. Givens, A.D. Beswick, A.M. Fehily, J.E. Pickering, and J. Gallacher The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer J. Am. Coll. Nutr. 27 2008 723s 734s
73. R. Sprong, A. Schonewille, and R. Van der Meer Dietary cheese whey protein protects rats against mild dextran sulfate sodium-induced colitis: role of mucin and microbiota J. Dairy Sci. 93 2010 1364 1371
74. L. McAllan Protein quality and the protein to carbohydrate ratio within a high fat diet influences energy balance and the gut microbiota in C57BL/6J mice PLoS One 9 2014 e88904
75. J.H. Cummings, and H.N. Englyst What is dietary fibre? Trends Food Sci. Technol. 2 1991 99 103
76. G.R. Gibson, and M.B. Roberfroid Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics J. Nutr. 125 1995 1401 1412
77. G.R. Gibson, H.M. Probert, J. Van Loo, R.A. Rastall, and M.B. Roberfroid Dietary modulation of the human colonic microbiota: updating the concept of prebiotics Nutr. Res. Rev. 17 2004 259 275
78. A. Costabile, S. Kolida, A. Klinder, E. Gietl, M. Bäuerlein, C. Frohberg, V. Landschütze, and G.R. Gibson A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects Br. J. Nutr. 104 2010 1007
79. P.T. Koleva, R.S. Valcheva, X. Sun, M.G. Gänzle, and L.A. Dieleman Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats Br. J. Nutr. 108 2012 1633 1643
80. P. Ramnani, E. Gaudier, M. Bingham, P. Van Bruggen, K.M. Tuohy, and G.R. Gibson Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study Br. J. Nutr. 104 2010 233 240
81. S. Lewis, J. Brazier, D. Beard, N. Nazem, and D. Proctor Effects of metronidazole and oligofructose on faecal concentrations of sulphate-reducing bacteria and their activity in human volunteers Scand. J. Gastroenterol. 40 2005 1296 1303
82. A.-J. Waligora-Dupriet, F. Campeotto, I. Nicolis, A. Bonet, P. Soulaines, C. Dupont, and M.-J. Butel Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre Int. J. Food Microbiol. 113 2007 108 113
83. Y. Bouhnik, L. Raskine, G. Simoneau, E. Vicaut, C. Neut, B. Flourié, F. Brouns, and F.R. Bornet The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study Am. J. Clin. Nutr. 80 2004 1658 1664
84. F. Respondek, K.S. Swanson, K.R. Belsito, B.M. Vester, A. Wagner, L. Istasse, and M. Diez Short-chain fructooligosaccharides influence insulin sensitivity and gene expression of fat tissue in obese dogs J. Nutr. 138 2008 1712 1718
85. J. Slavin Fiber and prebiotics: mechanisms and health benefits Nutrients 5 2013 1417 1435
86. M. Roberfroid Prebiotic effects: metabolic and health benefits Br. J. Nutr. 104 Suppl. 2 2010 S1 S63
87. A.T. Vieira, M.M. Teixeira, and F.S. Martins The role of probiotics and prebiotics in inducing gut immunity Front. Immunol. 4 2013 445
88. F. De Vadder, P. Kovatcheva-Datchary, D. Goncalves, J. Vinera, C. Zitoun, A. Duchampt, F. Bäckhed, and G. Mithieux Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits Cell 156 2014 84 96
89. L. Gabert 13C tracer recovery in human stools after digestion of a fat-rich meal labelled with [1, 1, 1-13C3]tripalmitin and [1, 1, 1-13C3]triolein Rapid Commun. Mass Spectrom. 25 2011 2697 2703
90. E.F. Murphy Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models Gut 59 2010 1635 1642
91. M.A. Hildebrandt High-fat diet determines the composition of the murine gut microbiome independently of obesity Gastroenterology 137 2009 1716-1724.e2
92. H. Daniel High-fat diet alters gut microbiota physiology in mice ISME J. 2013
93. C. Zhang Structural modulation of gut microbiota in life-long calorie-restricted mice Nat. Commun. 4 2013
94. K.P. Scott, S.W. Gratz, P.O. Sheridan, H.J. Flint, and S.H. Duncan The influence of diet on the gut microbiota Pharmacol. Res. 69 2013 52 60
95. W. Shen, H.R. Gaskins, and M.K. McIntosh Influence of dietary fat on intestinal microbes, inflammation, barrier function and metabolic outcomes J. Nutr. Biochem. 2013
96. C. De Filippo Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa Proc. Natl. Acad. Sci. 107 2010 14691 14696
97. K. Liszt, J. Zwielehner, M. Handschur, B. Hippe, R. Thaler, and A.G. Haslberger Characterization of bacteria, clostridia and bacteroides in faeces of vegetarians using qPCR and PCR-DGGE fingerprinting Ann. Nutr. Metab. 54 2009 253 257
98. J. Kabeerdoss, R.S. Devi, R.R. Mary, and B.S. Ramakrishna Faecal microbiota composition in vegetarians: comparison with omnivores in a cohort of young women in southern India Br. J. Nutr. 108 2012 953 957
99. B.B. Matijasic, T. Obermajer, L. Lipoglavsek, I. Grabnar, G. Avgustin, and I. Rogelj Association of dietary type with fecal microbiota in vegetarians and omnivores in Slovenia Eur. J. Nutr. 2013
100. A. Cotillard Dietary intervention impact on gut microbial gene richness Nature 500 2013 585 588
101. J.J. Faith, N.P. McNulty, F.E. Rey, and J.I. Gordon Predicting a human gut microbiota's response to diet in gnotobiotic mice Science 333 2011 101 104
102. P.D. Cotter, C. Stanton, R.P. Ross, and C. Hill The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing Discovery Med. 13 2012 193
103. M. Blaser Antibiotic overuse: stop the killing of beneficial bacteria Nature 476 2011 393 394
104. Y. Chen, and M.J. Blaser Inverse associations of Helicobacter pylori with asthma and allergy Arch. Intern. Med. 167 2007 821 827
105. I.C. Arnold, N. Dehzad, S. Reuter, H. Martin, B. Becher, C. Taube, and A. Müller Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells J. Clin. Investig. 121 2011 3088 3093
106. M.C. Rea Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile Proc. Natl. Acad. Sci. 107 2010 9352 9357
107. C.A. Warren, and R.L. Guerrant Pathogenic C. difficile is here (and everywhere) to stay Lancet 377 2011 8 9
108. I. Cho Antibiotics in early life alter the murine colonic microbiome and adiposity Nature 488 2012 621 626
109. D.A. Antonopoulos, S.M. Huse, H.G. Morrison, T.M. Schmidt, M.L. Sogin, and V.B. Young Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation Infect. Immun. 77 2009 2367 2375
110. A.E. Perez-Cobas Differential effects of antibiotic therapy on the structure and function of human gut microbiota PLoS ONE 8 2013 e80201
111. P.D. Cotter, C. Hill, and R.P. Ross Bacteriocins: developing innate immunity for food Nat. Rev. Microbiol. 3 2005 777 788
112. E.F. O'Shea, G.E. Gardiner, P.M. O'Connor, S. Mills, R.P. Ross, and C. Hill Characterization of enterocin- and salivaricin-producing lactic acid bacteria from the mammalian gastrointestinal tract FEMS Microbiol. Lett. 291 2009 24 34
113. M.C. Rea Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon Proc. Natl. Acad. Sci. 108 2011 4639 4644
114. P.G. Casey, G.D. Casey, G.E. Gardiner, M. Tangney, C. Stanton, R.P. Ross, C. Hill, and G.F. Fitzgerald Isolation and characterization of anti-Salmonella lactic acid bacteria from the porcine gastrointestinal tract Lett. Appl. Microbiol. 39 2004 431 438
115. B. Lakshminarayanan, C.M. Guinane, P.M. O'Connor, M. Coakley, C. Hill, C. Stanton, P.W. O'Toole, and R.P. Ross Isolation and characterization of bacteriocin-producing bacteria from the intestinal microbiota of elderly Irish subjects J. Appl. Microbiol. 114 2013 886 898
116. M. Saarela, G. Mogensen, R. Fondén, J. Mättö, and T. Mattila-Sandholm Probiotic bacteria: safety, functional and technological properties J. Biotechnol. 84 2000 197 215
117. S.C. Corr, Y. Li, C.U. Riedel, P.W. O'Toole, C. Hill, and C.G.M. Gahan Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118 Proc. Natl. Acad. Sci. 104 2007 7617 7621
118. E. Riboulet-Bisson Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota PLoS ONE 7 2012 e31113
119. P.G. Casey A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium Appl. Environ. Microbiol. 73 2007 1858 1863
120. M.C. Walsh Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype FEMS Microbiol. Ecol. 64 2008 317 327
121. E.F. Murphy Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity Gut 62 2013 220 226
122. M. Pineiro, and C. Stanton Probiotic bacteria: legislative framework - requirements to evidence basis J. Nutr. 137 2007 850S 853S
123. U. Vyas, and N. Ranganathan Probiotics, prebiotics, and synbiotics: gut and beyond Gastroenterol. Res. Pract. 2012 2012 872716
124. C. Chapman, G. Gibson, and I. Rowland Health benefits of probiotics: are mixtures more effective than single strains? Eur. J. Nutr. 50 2011 1 17
125. G.T. Rijkers Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research J. Nutr. 140 2010 671s 676s
126. D.Y. Park Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity PLoS ONE 8 2013 e59470
127. H. Yadav, J.H. Lee, J. Lloyd, P. Walter, and S.G. Rane Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion J. Biol. Chem. 288 2013 25088 25097
128. N.P. McNulty The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins Sci. Transl. Med. 3 2011 106ra106
129. A.S. Andreasen, N. Larsen, T. Pedersen-Skovsgaard, R.M. Berg, K. Moller, K.D. Svendsen, M. Jakobsen, and B.K. Pedersen Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects Br. J. Nutr. 104 2010 1831 1838
130. L. Aronsson Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4) PLoS ONE 5 2010
131. Y. Kadooka Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial Eur. J. Clin. Nutr. 64 2010 636 643
132. C. Dai, C.Q. Zheng, M. Jiang, X.Y. Ma, and L.J. Jiang Probiotics and irritable bowel syndrome World J. Gastroenterol. 19 2013 5973 5980
133. L.R. Fitzpatrick Probiotics for the treatment of Clostridium difficile associated disease World J. Gastrointest. Pathophysiol. 4 2013 47 52
134. G.R. Veerappan, J. Betteridge, and P.E. Young Probiotics for the treatment of inflammatory bowel disease Curr. Gastroenterol. Rep. 14 2012 324 333
135. M. Miyoshi, A. Ogawa, S. Higurashi, and Y. Kadooka Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice Eur. J. Nutr. 2013
136. A. Neef, and Y. Sanz Future for probiotic science in functional food and dietary supplement development Curr. Opin. Clin. Nutr. Metab. Care 16 2013 679 687
137. A. Khoruts, J. Dicksved, J.K. Jansson, and M.J. Sadowsky Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea J. Clin. Gastroenterol. 44 2010 354 360
138. M. Tvede, and J. Rask-Madsen Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients Lancet 1 1989 1156 1160
139. J. Aas, C.E. Gessert, and J.S. Bakken Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube Clin. Infect. Dis. 36 2003 580 585
140. E. Gough, H. Shaikh, and A.R. Manges Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection Clin. Infect. Dis. 53 2011 994 1002
141. W.M. de Vos Fame and future of faecal transplantations - developing next-generation therapies with synthetic microbiomes Microb. Biotechnol. 6 2013 316 325
142. E.O. Petrof Stool substitute transplant therapy for the eradication of Clostridium difficile infection:'RePOOPulating'the gut Microbiome 1 2013 1 12
143. T.J. Borody, L.J. Brandt, and S. Paramsothy Therapeutic faecal microbiota transplantation: current status and future developments Curr. Opin. Gastroenterol. 30 2014 97 105